問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of General Internal Medicine

Division of Infectious Disease

更新時間:2023-09-19

盛望徽Sheng, Wang-Huei
  • Principal Investigator
  • Clinical Trial Experience (year) 24 years
  • vicky90180@gmail.com

篩選

List

34Cases

2016-08-01 - 2018-12-31

Phase III

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
7Sites

Terminated7Sites

2017-03-23 - 2021-05-03

Phase III

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
3Sites

Recruiting3Sites

2018-05-01 - 2023-05-17

Phase III

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
7Sites

Not yet recruiting6Sites

Terminated1Sites

2021-02-01 - 2026-12-31

Phase III

Active
A phase III, randomized, assessor-blinded, two-stage, two-way crossover, active-and-placebo controlled trial was conducted to evaluate the efficacy and safety of using chlorhexidine gluconate (Aqua)-containing antibacterial wipes as a topical disinfectant in healthy volunteers.
  • Condition/Disease

    Hand disinfection before surgery, hand disinfection in the ward, and skin disinfection for patients before surgery.

  • Test Drug

    liniment

Participate Sites
4Sites

Recruiting4Sites

2023-03-10 - 2024-11-14

Phase II

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
5Sites

Not yet recruiting4Sites

Terminated1Sites

2023-12-08 - 2024-09-30

Phase II/III

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
7Sites

Recruiting7Sites

2024-01-01 - 2025-09-30

Phase II

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
7Sites

Recruiting7Sites

2024-01-01 - 2025-09-30

Phase II

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
7Sites

Recruiting5Sites

Terminated2Sites

2024-12-01 - 2025-11-30

Phase III

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
8Sites

Recruiting8Sites

2021-09-01 - 2023-04-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting6Sites

Terminated2Sites

1 2 3 4